Side Population Cells from Human Melanoma Tumors Reveal Diverse Mechanisms for Chemoresistance

[1]  A. Jemal,et al.  Cancer statistics, 2011 , 2011, CA: a cancer journal for clinicians.

[2]  S. Martínez,et al.  Human Endometrial Side Population Cells Exhibit Genotypic, Phenotypic and Functional Features of Somatic Stem Cells , 2010, PloS one.

[3]  Chunxiao Zhou,et al.  Cancer stem cells sustaining the growth of mouse melanoma are not rare. , 2010, Cancer letters.

[4]  森脇 健太,et al.  Deficiency of GMDS Leads to Escape from NK Cell-Mediated Tumor Surveillance Through Modulation of TRAIL Signaling , 2010 .

[5]  J. Fletcher,et al.  ABC transporters in cancer: more than just drug efflux pumps , 2010, Nature Reviews Cancer.

[6]  F. Hodi,et al.  Tumor and Stem Cell Biology Cancer Research Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells , 2010 .

[7]  Yuchun Luo,et al.  Constitutively Active Inflammasome in Human Melanoma Cells Mediating Autoinflammation via Caspase-1 Processing and Secretion of Interleukin-1β* , 2009, The Journal of Biological Chemistry.

[8]  M. Gottesman,et al.  Involvement of ABC transporters in melanogenesis and the development of multidrug resistance of melanoma , 2009, Pigment cell & melanoma research.

[9]  R. Gutzmer,et al.  Effect of DNA repair host factors on temozolomide or dacarbazine melanoma treatment in Caucasians , 2009, Pharmacogenetics and genomics.

[10]  J. Dou,et al.  Identifying tumor stem‐like cells in mouse melanoma cell lines by analyzing the characteristics of side population cells , 2009, Cell biology international.

[11]  A. Hauschild,et al.  Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Giovanni Parmigiani,et al.  A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro. , 2009, Cancer research.

[13]  Tatsuya Ozawa,et al.  PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. , 2009, Cell stem cell.

[14]  M. Dean.  ABC Transporters, Drug Resistance, and Cancer Stem Cells , 2009, Journal of Mammary Gland Biology and Neoplasia.

[15]  J. Sanes,et al.  γ-Protocadherins regulate neuronal survival but are dispensable for circuit formation in retina , 2008, Development.

[16]  D. Waugh,et al.  The Interleukin-8 Pathway in Cancer , 2008, Clinical Cancer Research.

[17]  A. Corradin,et al.  The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects. , 2008, Cancer research.

[18]  Gideon Rechavi,et al.  MDR1 expression identifies human melanoma stem cells. , 2008, Biochemical and biophysical research communications.

[19]  Mohamed H. Sayegh,et al.  Identification of cells initiating human melanomas , 2008, Nature.

[20]  R. Béliveau,et al.  Modulation of P‐glycoprotein function by sphingosine kinase‐1 in brain endothelial cells , 2007, Journal of neurochemistry.

[21]  R. Hruban,et al.  An In vivo Platform for Translational Drug Development in Pancreatic Cancer , 2006, Clinical Cancer Research.

[22]  G. Tusnády,et al.  Membrane topology of human ABC proteins , 2006, FEBS letters.

[23]  W. Sadee,et al.  ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. , 2005, Cancer research.

[24]  Michael Dean,et al.  Tumour stem cells and drug resistance , 2005, Nature Reviews Cancer.

[25]  Keith W. Vance,et al.  Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas. , 2005, Cancer research.

[26]  M. Bar‐eli,et al.  Different signalling pathways regulate VEGF and IL-8 expression in breast cancer: implications for therapy. , 2004, European journal of cancer.

[27]  M. Goodell,et al.  A distinct "side population" of cells with high drug efflux capacity in human tumor cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Z. Duan,et al.  Inhibition of ABCB1 (MDR1) and ABCB4 (MDR3) expression by small interfering RNA and reversal of paclitaxel resistance in human ovarian cancer cells. , 2004, Molecular cancer therapeutics.

[29]  Theresa Smith,et al.  Phase II evaluation of paclitaxel by short intravenous infusion in metastatic melanoma , 2004, Melanoma research.

[30]  S. Narayan,et al.  Role of APC and DNA mismatch repair genes in the development of colorectal cancers , 2003, Molecular Cancer.

[31]  Marianne Fillet,et al.  NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cells , 2003, Oncogene.

[32]  Sophie Lelièvre,et al.  beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. , 2002, Cancer cell.

[33]  S. Gerson.  Clinical relevance of MGMT in the treatment of cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  A. Arlt,et al.  Autocrine Production of Interleukin 1β Confers Constitutive Nuclear Factor κB Activity and Chemoresistance in Pancreatic Carcinoma Cell Lines , 2002 .

[35]  D. Schadendorf,et al.  Drug‐resistance in human melanoma , 2001, International journal of cancer.

[36]  A. Rzhetsky,et al.  The human ATP-binding cassette (ABC) transporter superfamily. , 2001, Genome research.

[37]  R. Gaynor,et al.  Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. , 2001, The Journal of clinical investigation.

[38]  Ge Zhou,et al.  NF-κB-mediated Induction of mdr1b Expression by Insulin in Rat Hepatoma Cells* , 1997, The Journal of Biological Chemistry.

[39]  A. S. Conner,et al.  Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo , 1996, The Journal of experimental medicine.

[40]  N. Bleehen,et al.  Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  G. Malerba,et al.  Supplementary Figure S4 , 2012 .

[42]  A. Chinnaiyan,et al.  Supplementary Figure S3 , 2012 .

[43]  E. Solary,et al.  Supplementary Figure S1 , 2012 .

[44]  G. Malerba,et al.  Supplementary Figure S2 , 2012 .

[45]  C. L. La Porta.  Drug resistance in melanoma: new perspectives. , 2007, Current medicinal chemistry.

[46]  J. A. Burch,et al.  Melanoma, a tumor based on a mutant stem cell? , 2006, The Journal of investigative dermatology.

[47]  M. Gottesman,et al.  Multidrug resistance in cancer: role of ATP–dependent transporters , 2002, Nature Reviews Cancer.

[48]  A. Arlt,et al.  Autocrine production of interleukin 1beta confers constitutive nuclear factor kappaB activity and chemoresistance in pancreatic carcinoma cell lines. , 2002, Cancer research.

[49]  G. Zhou,et al.  NF-kappaB-mediated induction of mdr1b expression by insulin in rat hepatoma cells. , 1997, The Journal of biological chemistry.